Commentary|Videos|March 10, 2022
What Pharmacists Should Understand When Assessing, Treating Patients With Ovarian Cancer With Rucaparib
Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses what oncology pharmacists should understand about rucaparib when treating ovarian cancer.
Advertisement
Pharmacy Times interviewed Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, on what rucaparib is used to treat and how its mechanism of action works to fight cancer.
During the interview, Morris addressed what oncology pharmacists should understand when assessing and treating patients with ovarian cancer with rucaparib.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Round-Up: Every Most Favored Nation Agreement With the Trump Administration
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
4
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
5